These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26642707)

  • 1. Influence of Duration and Temperature of Transport and Storage Prior to Processing on Cell Quality of Cord Blood Units--A German. Experience.
    Strobel J; Brenner L; Zimmermann R; Weiss D; Zingsem J; Eckstein R; Weisbach V
    Clin Lab; 2015; 61(10):1453-61. PubMed ID: 26642707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of temperature treatment before cryopreservation on the viability and potency of cryopreserved and thawed CD34
    Schwandt S; Liedtke S; Kogler G
    Cytotherapy; 2017 Aug; 19(8):962-977. PubMed ID: 28645734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord blood CD34(+) stem cells and other mononuclear cell subtypes processed up to 96 h from collection and stored at room temperature maintain a satisfactory functionality for cell therapy.
    Pereira-Cunha FG; Duarte AS; Reis-Alves SC; Olalla Saad ST; Metze K; Lorand-Metze I; Luzo ÂC
    Vox Sang; 2015 Jan; 108(1):72-81. PubMed ID: 25333825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid storage, shipment, and cryopreservation of cord blood.
    Hubel A; Carlquist D; Clay M; McCullough J
    Transfusion; 2004 Apr; 44(4):518-25. PubMed ID: 15043567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries.
    Takahashi TA; Rebulla P; Armitage S; van Beckhoven J; Eichler H; Kekomäki R; Letowska M; Wahab F; Moroff G
    Cytotherapy; 2006; 8(3):254-64. PubMed ID: 16793734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of cord blood after liquid storage.
    Hubel A; Carlquist D; Clay M; McCullough J
    Cytotherapy; 2003; 5(5):370-6. PubMed ID: 14578099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality comparison of umbilical cord blood cryopreserved with conventional versus automated systems.
    Kim KM; Huh JY; Kim JJ; Kang MS
    Cryobiology; 2017 Oct; 78():65-69. PubMed ID: 28716596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cryopreservation on the immunogenicity of umbilical cord blood cells.
    Ketheesan N; Whiteman C; Malczewski AB; Hirst RG; La Brooy JT
    Transfus Apher Sci; 2004 Feb; 30(1):47-54. PubMed ID: 14746821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful short-term cryopreservation of volume-reduced cord blood units in a cryogenic mechanical freezer: effects on cell recovery, viability, and clonogenic potential.
    Anagnostakis I; Papassavas AC; Michalopoulos E; Chatzistamatiou T; Andriopoulou S; Tsakris A; Stavropoulos-Giokas C
    Transfusion; 2014 Jan; 54(1):211-23. PubMed ID: 23692393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of optimal conditions for collection and cryopreservation of umbilical cord hematopoietic cells.
    Campos L; Roubi N; Guyotat D
    Cryobiology; 1995 Dec; 32(6):511-5. PubMed ID: 8556857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of processing and cryopreservation on nucleated umbilical cord blood cells.
    Bayer-Zwirello LA; Hoffman DE; Adams LA; Wilder PT; Reece MT
    J Perinat Med; 2004; 32(5):430-3. PubMed ID: 15493721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viability of umbilical cord blood mononuclear cell subsets until 96 hours after collection.
    Pereira-Cunha FG; Duarte AS; Costa FF; Saad ST; Lorand-Metze I; Luzo AC
    Transfusion; 2013 Sep; 53(9):2034-42. PubMed ID: 23320473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.
    Minegishi M; Itoh T; Fukawa N; Kitaura T; Miura J; Takahashi H; Suzuki A; Kudo Y; Narita A; Sato Y; Suzuki M; Watanabe T; Wada Y; Takeyama Y; Tsuchiya S
    Int J Hematol; 2007 Jan; 85(1):78-84. PubMed ID: 17261506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-laboratory assay for harmonization of enumeration of viable CD34+ and CD45+ cells in frozen cord blood units.
    Fournier D; Lewin A; Simard C; Trépanier P; Néron S; Ballerini L; Codinach M; Elmoazzen H; Halpenny M; Kogler G; Liedtke S; Louis I; Molluna CA; Pineault N; Prasath A; Querol S; Saccardi R; Sutherland DR; Thérien C; Urbani S
    Cytotherapy; 2020 Jan; 22(1):44-51. PubMed ID: 31883947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
    Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
    Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cryopreservation on umbilical blood cells and its mechanism].
    Li X; Chen F; Jiang T; Wang E; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):709-14. PubMed ID: 23908089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells.
    Yang H; Pidgorna A; Loutfy MR; Shuen P
    Transfusion; 2015 Jan; 55(1):70-8. PubMed ID: 25039650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing cord blood viability assessment before cryopreservation.
    Solomon M; Wofford J; Johnson C; Regan D; Creer MH
    Transfusion; 2010 Apr; 50(4):820-30. PubMed ID: 19919556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Storage characteristics of cord blood progenitor cells: report of a multicenter study by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
    Pamphilon D; Curnow E; Belfield H; Reems JA; McMannis J; Lecchi L; Szczepiorkowski Z; McKenna D
    Transfusion; 2011 Jun; 51(6):1284-90. PubMed ID: 21133927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.